Search Results - "Borbon, Luis C."

Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy by Tran, Catherine G, Borbon, Luis C, Mudd, Jacqueline L, Abusada, Ellen, AghaAmiri, Solmaz, Ghosh, Sukhen C, Vargas, Servando Hernandez, Li, Guiying, Beyer, Gabriella V, McDonough, Mary, Li, Rachel, Chan, Carlos H F, Walsh, Susan A, Wadas, Thaddeus J, O'Dorisio, Thomas, O'Dorisio, M Sue, Govindan, Ramaswamy, Cliften, Paul F, Azhdarinia, Ali, Bellizzi, Andrew M, Fields, Ryan C, Howe, James R, Ear, Po Hien

“…Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs) are rare cancers consisting of neuroendocrine carcinomas (NECs) and neuroendocrine tumors (NETs),…”
Get full text

Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors by Borbon, Luis C., Sherman, Scott K., Breheny, Patrick J., Chandrasekharan, Chandrikha, Menda, Yusuf, Bushnell, David, Bellizzi, Andrew M., Ear, P. H., O’Dorisio, M. Sue, O’Dorisio, Thomas M., Dillon, Joseph S., Howe, James R.

“…Peptide receptor radionuclide therapy (PRRT) is an effective treatment for advanced gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). We investigated…”
Get full text

Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? by Borbon, Luis C., Tran, Catherine G., Sherman, Scott K., Ear, Po Hien, Chandrasekharan, Chandrikha, Bellizzi, Andrew M., Dillon, Joseph S., O’Dorisio, Thomas M., Howe, James R.

“…Background Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are aggressive tumors with poor survival outcomes for which medical…”
Get full text

Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysis by Ziogas, Ioannis A., Tasoudis, Panagiotis T., Borbon, Luis C., Sherman, Scott K., Breheny, Patrick J., Chandrasekharan, Chandrikha, Dillon, Joseph S., Bellizzi, Andrew M., Howe, James R.

“…Background Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are rare, aggressive tumors with poor prognosis. The World Health…”
Get full text

ASO Visual Abstract: Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms—A Systematic Review and Meta-Analysis by Ziogas, Ioannis A., Tasoudis, Panagiotis T., Borbon, Luis C., Sherman, Scott K., Breheny, Patrick J., Chandrasekharan, Chandrikha, Dillon, Joseph S., Bellizzi, Andrew M., Howe, James R.

Get full text

ASO Visual Abstract: Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? by Borbon, Luis C., Tran, Catherine G., Sherman, Scott K., Ear, Po Hien, Chandrasekharan, Chandrikha, Bellizzi, Andrew M., Dillon, Joseph S., O’Dorisio, Thomas M., Howe, James R.

Get full text

High-Contrast Detection of Somatostatin Receptor Subtype‑2 for Fluorescence-Guided Surgery by Hernandez Vargas, Servando, AghaAmiri, Solmaz, Ghosh, Sukhen C., Luciano, Michael P., Borbon, Luis C., Ear, Po Hien, Howe, James R., Bailey-Lundberg, Jennifer M., Simonek, Gregory D., Halperin, Daniel M., Tran Cao, Hop S., Ikoma, Naruhiko, Schnermann, Martin J., Azhdarinia, Ali

“…Dye design can influence the ability of fluorescently labeled imaging agents to generate tumor contrast and has become an area of significant interest in the…”
Get full text

Abstract 3578: A systematic NEN spheroid drug screen reveals a novel drug resistance mechanism in small bowel NETs by Tran, Catherine G., Borbon, Luis C., Tow, Dane H., Shilyansky, Jonathan, Li, Guiying, Egan, James, Sherman, Scott K., Abusada, Ellen, Tang, Jing, govindan, Ramaswamy, Fields, Ryan C., Braun, Terry A., Chan, Carlos HF, Chandrasekharan, Chandrikha, Spitz, Douglas, Quelle, Dawn E., Bellizzi, Andrew M., Howe, James R., Ear, Po Hien

“…Abstract Neuroendocrine neoplasms (NENs) are rare cancers that arise from neuroendocrine cells. NENs are classified as well-differentiated neuroendocrine…”
Get full text